Sponsor or institution
Clinical trials and research at CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.
As of November 12, 2026, Find a Trial lists 9 clinical trials run by CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. that are recruiting, in China. By phase: Phase 1 (4), Phase 3 (2), Phase 2 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 9Clinical trials
- 1Country
Newest trials
All recruiting trials (9)
-
SYH2070 injection for mixed hyperlipidemia
This phase 2 study tests whether the SYH2070 injection can lower lipids compared with placebo in adults with mixed hyperlipidemia who are on statin therapy.
-
SYH2070 injection for homozygous familial hypercholesterolemia
A phase 2 study tests SYH2070 injections in adults with HoFH who are already on lipid-lowering therapy to see if it helps lower their cholesterol safely.
-
Comparing a new 3‑month paliperidone palmitate injection with Invega Trinza for people with schizophrenia
This study will test whether a 3‑month paliperidone palmitate injection made by CSPC works the same as Invega Trinza for adults with schizophrenia.
-
SYH2053 Injection for adults with heterozygous familial hypercholesterolemia
A phase 3 trial tests whether SYH2053 injection, added to standard diet and statin therapy, can lower LDL cholesterol in adults with HeFH compared with placebo.
-
SYH2053 monotherapy for Chinese adults with non‑familial high cholesterol or mixed hyperlipidemia
This trial will test whether SYH2053 injections alone can safely lower LDL cholesterol in Chinese adults with non‑familial high cholesterol or mixed high lipids.
-
Single ascending-dose safety and response test of SYH2070 injection in healthy adults
This test gives a single subcutaneous dose of SYH2070 to healthy adults with mildly high triglycerides to see whether it is safe, how the body handles it, and whether it causes early biological effects compared with placebo.
-
SYH2061 first-in-human single-dose safety test in healthy adults
A single-dose test of SYH2061 vs placebo in healthy adults to see if it is safe and well tolerated and to understand how it behaves in the body.
-
Compare a 100 mg albumin‑bound paclitaxel product with Abraxane® in breast cancer patients
This test sees if a 100 mg albumin‑bound paclitaxel product acts the same as Abraxane® in adults with confirmed breast cancer who are candidates for paclitaxel monotherapy.
-
Evaluating SYH2062 Injection in Healthy Chinese Volunteers
This study is testing a new injection called SYH2062 in healthy Chinese volunteers to see if it's safe and how it works in the body.
Quick answers
How many clinical trials run by CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. are recruiting right now?
9, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 4, Phase 3: 2, Phase 2: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.